CMS in a final Medicare Advantage and Part D drug pricing rule posted last month may have notably walked back proposals around “protected” drug classes and pharmacy price concessions, but one item the agency finalized with a few tweaks is a requirement that Part D sponsors implement an electronic Real-Time Benefit Tool (RTBT). While the […]
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.